Home / Cell Biology / Signal Transduction / Transcription Factors / Nrf2 / Nrf2 Activators / CDDO-Me

CDDO-Me

Cat. No. 6646 Submit a Review Datasheet / COA / SDS

Discontinued Product

6646 has been discontinued.

View all Nrf2 products.
Description: Nrf2 pathway activator; also NF-κB pathway inhibitor; inhibits IKKβ
Chemical Name: 2-Cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid methyl ester
Datasheet
Citations
Reviews
Literature (2)
Biological Activity Technical Data Datasheets References

Biological Activity for CDDO-Me

CDDO-Me is a Nrf2 pathway activator. Induces expression of Nrf-2 regulated, cytoprotective genes in vivo. Also blocks the NF-κB pathway by direct inhibition of IKKβ. Inhibits production of a wide range of inflammatory mediators in vitro.

Technical Data for CDDO-Me

M. Wt 505.69
Formula C32H43NO4
Storage Store at -20°C
CAS Number 218600-53-4
PubChem ID 400769
InChI Key WPTTVJLTNAWYAO-KPOXMGGZSA-N
Smiles [H][C@@]12CC(C)(CC[C@]1(C(OC)=O)CC[C@@]3([C@@]2(C(C=C4[C@]3(CC[C@]5(C(C)(C(C(C#N)=C[C@]45C)=O)C)[H])C)=O)[H])C)C

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

References for CDDO-Me

References are publications that support the biological activity of the product.

Ahmad et al (2006) Triterpenoid CDDO-Me blocks the NF-κB pathway by direct inhibition of IKKβ on Cys-179. J.Biol.Chem. 281 35764 PMID: 16998237

Yates et al (2007) Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes. Mol.Cancer Ther. 6 154 PMID: 17237276

Liby & Sporn (2012) Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease. Pharmacol.Rev. 64 972 PMID: 22966038

View Related Products by Target

View Related Products by Product Action

View all Nrf2 Activators

Keywords: CDDO-Me, CDDO-Me supplier, CDDO, methyl, ester, bardoxolone, Nrf2, activators, activates, NF-kappaB, inhibitors, inhibits, IKKbeta, IkappaB, NF-kB/IkB, IkB, Kinase, 6646, Tocris Bioscience

Citations for CDDO-Me

Citations are publications that use Tocris products.

Currently there are no citations for CDDO-Me.

Reviews for CDDO-Me

There are currently no reviews for this product. Be the first to review CDDO-Me and earn rewards!

Have you used CDDO-Me?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.

Cancer Metabolism Research Product Guide

Cancer Metabolism Research Product Guide

This product guide reviews some of the main areas in cancer metabolism research and lists around 150 products that can be used to investigate metabolic pathways in cancer including:

Cancer Metabolism Poster

Cancer Metabolism Poster

This poster summarizes the main metabolic pathways in cancer cells and highlights potential targets for cancer therapeutics. Genetic changes and epigenetic modifications in cancer cells alter the regulation of cellular metabolic pathways providing potential cancer therapeutic targets.